Lightning Round: Sarepta Therapeutics, Splunk, Sony and More

Friday, 21 Sep 2012 | 7:01 PM ET

Franco-Nevada : Jim Cramer called this stock a "winner."

Sarepta Therapeutics : Cramer likes this stock right now, but only on a speculative basis.

Splunk : The "Mad Money" host can't recommend this stock right now.

Lightning Round
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

Boardwalk Pipeline Partners : This is one of Cramer's favorite master limited partnerships in the pipeline space.

Under Armour : While this company is doing good, Cramer noted it's chart is doing bad.

Sony : This is one bad stock that lacks a catalyst to push higher, Cramer said.

@MadMoneyOnCNBC on Twitter

"Mad Money" on Facebook

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com



  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."